Nobel Laureate for mRNA Vax Warned of Specific Risks in 2018 Paper


(Jacob Bruns, Headline USA) One of the two scientists who won the Nobel Prize in medicine on Monday for discoveries that enabled the creation of the deadly mRNA vaccines used against COVID-19 had previously warned about the potential dangers ofexperimental shots in a 2018 paper.

Drew Weissman, the director of vaccine research at the University of Pennsylvania, was one of four co-authors on the paper, titled “mRNA vaccines— a new era in vaccinology,” which was published in the January 2018 editon of Nature Reviews Drug Discovery.

In what would prove to be a prescient omen for what lay ahead, the researchers warned about mRNA jab toxicity, which could trigger “hyper-infammatory responses” along with other troublesome autoimmune side effects.

According to the text of the study itself, mRNA vaccines would not be viable until “potential safety concerns” were properly “evaluated in future preclinical and clinical studies.”

Such side effects would potentially include “local and systemic inflammation, the biodistribution and persistence of expressed immunogen, stimulation of auto-reactive antibodies and potential toxic effects of any non-native nucleotides and delivery system components.”

Those conducting the study also noted that such vaccines would also unlikely be safe for those with preexisting autoimmune troubles.

Moreover, “another potential safety issue could derive from the presence of extracellular RNA during mRNA vaccination.”

In other words, mRNA jabs could contribute to edemas, as well as “blood coagulation,” which can be difficult on the heart, both of which can even lead to heart failure.

But, unperturbed by his contributions to numerous deaths and other health complications, Weissman celebrated the triumph of mRNA vaccines in the wake of COVID and the government jab mandates.

“The future is just so incredible,” mused Weissman, 64, following the Nobel announcement. “We’ve been thinking for years about everything that we could do with RNA, and now it’s here.”